Monogram Orthopaedics, Inc. (MGRM)
USD 2.31
(-14.78%)
USD 2.31
(-14.78%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 16.57 Million USD | 21.1% |
| 2022 | 13.69 Million USD | 57.08% |
| 2021 | 8.71 Million USD | 7.39% |
| 2020 | 8.11 Million USD | 209.75% |
| 2019 | 2.62 Million USD | 121.25% |
| 2018 | 1.18 Million USD | 216.58% |
| 2017 | 374.07 Thousand USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 12.54 Million USD | -24.35% |
| 2024 Q2 | 9.81 Million USD | -21.73% |
| 2023 FY | 16.57 Million USD | 21.1% |
| 2023 Q4 | 16.57 Million USD | -9.08% |
| 2023 Q1 | 10.58 Million USD | -22.65% |
| 2023 Q3 | 18.23 Million USD | -11.96% |
| 2023 Q2 | 20.71 Million USD | 95.6% |
| 2022 Q4 | 13.69 Million USD | 0.0% |
| 2022 Q2 | 12.92 Million USD | 0.0% |
| 2022 Q1 | - USD | -100.0% |
| 2022 FY | 13.69 Million USD | 57.08% |
| 2021 Q1 | 9.53 Million USD | 17.49% |
| 2021 FY | 8.71 Million USD | 7.39% |
| 2021 Q4 | 8.71 Million USD | 0.0% |
| 2021 Q3 | 8.71 Million USD | -8.6% |
| 2021 Q2 | 9.53 Million USD | 0.0% |
| 2020 FY | 8.11 Million USD | 209.75% |
| 2020 Q4 | 8.11 Million USD | 0.0% |
| 2020 Q3 | 8.11 Million USD | -24.83% |
| 2020 Q2 | 10.79 Million USD | 0.0% |
| 2020 Q1 | 10.79 Million USD | 312.05% |
| 2019 Q4 | 2.62 Million USD | 0.0% |
| 2019 Q3 | 2.62 Million USD | 480.7% |
| 2019 Q2 | 451.2 Thousand USD | 0.0% |
| 2019 Q1 | 451.2 Thousand USD | -61.9% |
| 2019 FY | 2.62 Million USD | 121.25% |
| 2018 Q4 | 1.18 Million USD | 0.0% |
| 2018 Q1 | - USD | 0.0% |
| 2018 Q3 | 1.18 Million USD | 0.0% |
| 2018 FY | 1.18 Million USD | 216.58% |
| 2017 FY | 374.07 Thousand USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 31.36 Million USD | 47.143% |
| BrainsWay Ltd. | 62.97 Million USD | 73.672% |
| Cerus Corporation | 197.74 Million USD | 91.616% |
| Envoy Medical, Inc. | 7.64 Million USD | -117.003% |
| electroCore, Inc. | 16.38 Million USD | -1.172% |
| Helius Medical Technologies, Inc. | 7.69 Million USD | -115.536% |
| IceCure Medical Ltd | 16.41 Million USD | -1.03% |
| Inogen, Inc. | 326.19 Million USD | 94.917% |
| OrthoPediatrics Corp. | 449.58 Million USD | 96.312% |
| Lucid Diagnostics Inc. | 27.27 Million USD | 39.204% |
| MaxCyte, Inc. | 268.27 Million USD | 93.82% |
| NeuroOne Medical Technologies Corporation | 8.09 Million USD | -104.747% |
| Nexalin Technology, Inc. | 3.63 Million USD | -356.481% |
| Orthofix Medical Inc. | 925.31 Million USD | 98.208% |
| PAVmed Inc | 33.11 Million USD | 49.941% |
| Rapid Micro Biosystems, Inc. | 143.45 Million USD | 88.443% |
| RxSight, Inc. | 182.55 Million USD | 90.918% |
| Sight Sciences, Inc. | 166.65 Million USD | 90.052% |
| SI-BONE, Inc. | 230.42 Million USD | 92.805% |
| TELA Bio, Inc. | 78.04 Million USD | 78.758% |
| Treace Medical Concepts, Inc. | 251.9 Million USD | 93.419% |
| Vivos Therapeutics, Inc. | 10.73 Million USD | -54.511% |
| Acutus Medical, Inc. | 53.96 Million USD | 69.275% |
| Talis Biomedical Corporation | 98.34 Million USD | 83.141% |
| Spectral AI, Inc. | 10.69 Million USD | -55.06% |
| Nano-X Imaging Ltd. | 218.64 Million USD | 92.417% |
| CVRx, Inc. | 115.22 Million USD | 85.612% |
| DIH Holding US, Inc. Warrants | 58.66 Million USD | 71.738% |
| PetVivo Holdings, Inc. | 3.11 Million USD | -432.188% |
| Bioventus Inc. | 810.91 Million USD | 97.956% |
| Venus Concept Inc. | 93.65 Million USD | 82.298% |
| TriSalus Life Sciences, Inc. | 25.72 Million USD | 35.553% |
| LivaNova PLC | 2.42 Billion USD | 99.318% |
| 908 Devices Inc. | 202.98 Million USD | 91.832% |
| Alphatec Holdings, Inc. | 805.2 Million USD | 97.941% |
| Nemaura Medical Inc. | 14.56 Million USD | -13.842% |
| NeuroPace, Inc. | 107.65 Million USD | 84.599% |
| LENSAR, Inc. | 69.58 Million USD | 76.174% |
| Apyx Medical Corporation | 79.24 Million USD | 79.077% |
| Cutera, Inc. | 346.29 Million USD | 95.212% |
| STRATA Skin Sciences, Inc. | 42.01 Million USD | 60.541% |
| BioSig Technologies, Inc. | 1.79 Million USD | -822.081% |
| Anika Therapeutics, Inc. | 270.63 Million USD | 93.874% |
| ClearPoint Neuro, Inc. | 42.66 Million USD | 61.138% |
| Integra LifeSciences Holdings Corporation | 3.78 Billion USD | 99.562% |
| Axonics, Inc. | 719.92 Million USD | 97.697% |
| Outset Medical, Inc. | 313.8 Million USD | 94.717% |
| IRIDEX Corporation | 34.43 Million USD | 51.856% |
| PROCEPT BioRobotics Corporation | 404.71 Million USD | 95.904% |
| IRadimed Corporation | 92.15 Million USD | 82.01% |
| Tivic Health Systems, Inc. | 5.25 Million USD | -215.55% |
| INVO Bioscience, Inc. | 20.88 Million USD | 20.628% |
| Telesis Bio, Inc. | 70.41 Million USD | 76.454% |
| Viemed Healthcare, Inc. | 154.1 Million USD | 89.242% |
| Varex Imaging Corporation | 1.24 Billion USD | 98.673% |
| Quipt Home Medical Corp. | 247.4 Million USD | 93.299% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -78.077% |
| Pulmonx Corporation | 178.95 Million USD | 90.735% |
| Dynatronics Corporation | 25.94 Million USD | 36.088% |
| Modular Medical, Inc. | 13.8 Million USD | -20.077% |
| ReShape Lifesciences Inc. | 10.72 Million USD | -54.554% |
| Semler Scientific, Inc. | 78.06 Million USD | 78.763% |
| InMode Ltd. | 863.28 Million USD | 98.08% |
| Bruker Corporation | 4.24 Billion USD | 99.61% |
| Cytosorbents Corporation | 53.26 Million USD | 68.872% |
| DexCom, Inc. | 6.26 Billion USD | 99.735% |
| Align Technology, Inc. | 6.08 Billion USD | 99.727% |
| Viveve Medical, Inc. | 25.91 Million USD | 36.02% |
| ZimVie Inc. | 1.2 Billion USD | 98.625% |
| Movano Inc. | 9.42 Million USD | -75.979% |
| Cytek Biosciences, Inc. | 497.66 Million USD | 96.669% |
| Nexalin Technology, Inc. | 3.63 Million USD | -356.481% |
| DIH Holdings US, Inc. Class A Common Stock | 58.66 Million USD | 71.738% |
| Tandem Diabetes Care, Inc. | 952.65 Million USD | 98.26% |
| Profound Medical Corp. | 43.68 Million USD | 62.05% |
| Insulet Corporation | 2.58 Billion USD | 99.359% |
| enVVeno Medical Corporation | 48.63 Million USD | 65.911% |
| Surmodics, Inc. | 185.73 Million USD | 91.074% |
| iCAD, Inc. | 41.41 Million USD | 59.971% |
| Nuwellis, Inc. | 9.77 Million USD | -69.693% |
| Biotricity, Inc. | 5.94 Million USD | -178.985% |
| iRhythm Technologies, Inc. | 433.14 Million USD | 96.172% |
| Aethlon Medical, Inc. | 8.24 Million USD | -101.056% |
| InspireMD, Inc. | 47.64 Million USD | 65.202% |
| PAVmed Inc. | 33.11 Million USD | 49.941% |
| BIOLASE, Inc. | 35.1 Million USD | 52.768% |
| Beyond Air, Inc. | 56.96 Million USD | 70.894% |
| FONAR Corporation | 214.24 Million USD | 92.262% |
| AxoGen, Inc. | 196.82 Million USD | 91.577% |
| Vivani Medical, Inc. | 45.79 Million USD | 63.799% |
| Tactile Systems Technology, Inc. | 281.43 Million USD | 94.109% |
| Inari Medical, Inc. | 674.23 Million USD | 97.541% |
| UFP Technologies, Inc. | 404.13 Million USD | 95.898% |
| QT Imaging Holdings, Inc. | 23.39 Million USD | 29.145% |
| Heart Test Laboratories, Inc. | 9.5 Million USD | -74.459% |
| Tenon Medical, Inc. | 6.34 Million USD | -161.292% |
| Autonomix Medical, Inc. Common Stock | 9.4 Million USD | -76.241% |
| Co-Diagnostics, Inc. | 103.64 Million USD | 84.004% |
| AdaptHealth Corp. | 4.61 Billion USD | 99.641% |
| Sintx Technologies, Inc. | 15.36 Million USD | -7.901% |
| NanoVibronix, Inc. | 6.67 Million USD | -148.412% |
| Quanterix Corporation | 425.01 Million USD | 96.099% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -78.077% |
| Sensus Healthcare, Inc. | 53.72 Million USD | 69.142% |
| Pacific Biosciences of California, Inc. | 1.74 Billion USD | 99.05% |
| TransMedics Group, Inc. | 706.04 Million USD | 97.652% |
| ReWalk Robotics Ltd. | 63.19 Million USD | 73.764% |
| NeuroMetrix, Inc. | 21.42 Million USD | 22.616% |
| Hyperfine, Inc. | 94.19 Million USD | 82.4% |
| Establishment Labs Holdings Inc. | 268.64 Million USD | 93.829% |
| Biomerica, Inc. | 9.25 Million USD | -79.155% |
| Bone Biologics Corporation | 3.73 Million USD | -343.554% |
| AVITA Medical, Inc. | 144.33 Million USD | 88.514% |
| Bluejay Diagnostics, Inc. | 4.86 Million USD | -240.534% |
| Silk Road Medical, Inc | 265.3 Million USD | 93.751% |